Marketing-authorisation holder · Poland
GEDEON RICHTER POLSKA Sp. z o.o
6 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Poland
6 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BELARA 2 mg/0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULA2 mg + 0,03 mg · Comprimido recubierto con película | Clormadinona, Ethinyl estradiol | Spain | Marketed | 2021 |
| BELARA 2 mg/0,03 mg COMPRIMIDOS RECUBIERTOS CON PELICULA2,00 mg + 0,03 mg · Comprimido recubierto con película | Clormadinona, Ethinyl estradiol | Spain | Marketed | 2021 |
| VIDONORM 10MG/4MG TABLET | Amlodipine, Perindopril | Saudi Arabia | Authorised | |
| VIDONORM 10MG/8MG TABLET | Amlodipine, Perindopril | Saudi Arabia | Authorised | |
| VIDONORM 5MG/4MG TABLET | Amlodipine, Perindopril | Saudi Arabia | Authorised | |
| VIDONORM 5MG/8MG TABLET | Amlodipine, Perindopril | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Saudi Arabia | 4 | 4 | 0 | CompaniesAll medicines |
| Spain | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of Croatia, Serbia, United Kingdom
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.